| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 40,317 | 47,048 | 54,662 | 55,866 | | Cost of Revenue | 26,132 | 31,339 | 36,886 | 33,649 | | | Gross Profit | 14,185 | 15,709 | 17,776 | 22,217 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,554 | 10,353 | 11,129 | 12,336 | | Non Recurring | (195) | 223 | (28) | 34 | | Others | 3,270 | 3,122 | 2,831 | 2,650 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,371 | 2,011 | 3,844 | 7,197 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (206) | (28) | (40) | (37) | | Earnings Before Interest And Taxes | 3,350 | 1,983 | 3,804 | 7,160 | | Interest Expense | 960 | 974 | 961 | 541 | | Income Before Tax | 2,390 | 1,009 | 2,843 | 6,619 | | Income Tax Expense | 1,568 | 290 | 897 | 1,478 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 822 | 719 | 1,946 | 5,141 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 822 | 719 | 1,946 | 5,141 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $822 | $719 | $1,946 | $5,141 |
|
0.05% Nasdaq 
0.18%
Income Statement
